Publications by authors named "Helena Colom"

Claim this Profile
T
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation.
Anna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Gema Cerezo, Ana Coloma, Helena Colom

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients.
Marith I Francke, Sebastiaan D T Sassen, Nuria Lloberas, Helena Colom, Laure Elens

Clin Pharmacokinet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study.
Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Ana Coloma, Helena Colom

Pharmaceutics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of levetiracetam in patients diagnosed with refractory epilepsy: A real-world study.
Rui Silva, Helena Colom, Anabela Almeida, Joana Bicker, Andreia Carona

Epilepsia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new population pharmacokinetic model for dosing optimization of zonisamide in patients with refractory epilepsy.
Rui Silva, Helena Colom, Anabela Almeida, Joana Bicker, Andreia Carona

Eur J Pharm Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Customizing Tacrolimus Dosing in Kidney Transplantation: Focus on Pharmacogenetics.
Nuria Lloberas, Anna Vidal-Alabró, Helena Colom

Ther Drug Monit· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guiding the starting dose of the once-daily formulation of tacrolimus in " adult renal transplant patients: a population approach.
Beatriz Fernández-Alarcón, Oscar Nolberger, Anna Vidal-Alabró, Raul Rigo-Bonnin, Josep M Grinyó, Ana Coloma, Helena Colom

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.
Susana Clemente-Bautista, Iñaki F Trocóniz, Óscar Segarra-Cantón, Sara Salvador-Marín, Carlos J Parramón-Teixidó, Helena Colom

Paediatr Drugs· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.
Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Ana Coloma

Nefrologia (Engl Ed)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Hydroxytyrosol and Its Sulfate and Glucuronide Metabolites after the Oral Administration of Table Olives to Sprague-Dawley Rats.
Ivana Kundisová, Helena Colom, M Emília Juan, Joana M Planas

J Agric Food Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach.
Zeyar Mohammed Ali, Marinda Meertens, Beatriz Fernández, Pere Fontova, Anna Vidal-Alabró, Helena Colom

Pharmaceutics· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Nuria Lloberas, Josep M Grinyó, Helena Colom, Anna Vidal-Alabró, Pere Fontova, Ana Coloma

Kidney Int· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired-chronic or acute-hypofibrinogenaemia.
Helena Colom, Annabel Blasi, Bruno Montoro, Angel-Guillermo Arévalo, Josep Maria Cendrós

Br J Clin Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach.
Panagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, Marta Miarons, Beatriz Fernández-Alarcon, Helena Colom

Clin Pharmacokinet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment.
Núria Garrós, Paola Bustos-Salgados, Òscar Domènech, María José Rodríguez-Lagunas, Negar Beirampour, Helena Colom

Pharmaceuticals (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy.
Rui Silva, Helena Colom, Joana Bicker, Anabela Almeida, Ana Silva

Pharmaceutics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
Mar Ronda, Josep Manuel Llop-Talaveron, MariPaz Fuset, Elisabet Leiva, Evelyn Shaw, Helena Colom

Antibiotics (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations.
Pere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, Raül Rigo-Bonnin, Gema Cerezo, Ana Coloma, Helena Colom

Pharmaceutics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Approaches to Explore the Anticancer Potential of One Natural Flavanone and Four Derivatives Loaded in Biopolymeric Nanoparticles for Application in Topical Delivery Treatments.
Paola Bustos-Salgado, Berenice Andrade-Carrera, Valeri Domínguez-Villegas, Véronique Noé, Mireia Mallandrich, Helena Colom

Pharmaceutics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren's Syndrome.
Núria Garrós, Mireia Mallandrich, Negar Beirampour, Roya Mohammadi, Òscar Domènech, Helena Colom

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swine as the Animal Model for Testing New Formulations of Anti-Inflammatory Drugs: Carprofen Pharmacokinetics and Bioavailability of the Intramuscular Route.
Lidia Gómez-Segura, Antoni Boix-Montañes, Mireia Mallandrich, Alexander Parra-Coca, José L Soriano-Ruiz, Helena Colom

Pharmaceutics· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Transdermal Delivery of Pranoprofen Using a Thermo-Reversible Hydrogel Loaded with Lipid Nanocarriers for the Treatment of Local Inflammation.
María Rincón, Marcelle Silva-Abreu, Lupe Carolina Espinoza, Lilian Sosa, Ana Cristina Calpena, Helena Colom

Pharmaceuticals (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma idebenone monitoring in Friedreich's ataxia patients during a long-term follow-up.
Abraham J Paredes-Fuentes, Sergi Cesar, Raquel Montero, Cristina Latre, Jordi Genovès, Helena Colom

Biomed Pharmacother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, Oriol Bestard, Anna Vidal-Alabró, Ana Coloma

Clin Pharmacol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation.
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, Lisanne N van Merendonk, Anna Vidal-Alabró

Front Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis